HuGE Literature Finder
Records
1
-
3
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of personalized medicine 2022 4 12 (4): . Virgili Manrique Anna C, Salazar Juliana, Arranz María Jesús, Bagué Silvia, Orellana Ruth, López-Pousa Antonio, Cerdà Paula, Gracia Isidre, Majercakova Katarina, Peiró Ana, Trullols Laura, Fernández Manuel, Valverde Sandra, Quintana María Jesús, Bell Olga, Artigas-Baleri Alícia, Sebio A |
NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP. Chemotherapy 2018 Aug 63 (4): 191-197. Zhou Qidong, Ding Weihong, Weng Yingjie, Ding Guanxiong, Xia Guowei, Xu Jianfeng, Xu Ke, Ding Qia |
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 2008 Jun 112 (12): 2789-95. Blanco Javier G, Leisenring Wendy M, Gonzalez-Covarrubias Vanessa M, Kawashima Toana I, Davies Stella M, Relling Mary V, Robison Leslie L, Sklar Charles A, Stovall Marilyn, Bhatia Smi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: